As IL-8/CXCL8 circulating levels are elevated in COVID-19 patients with high lung function impairment (high admission RALE score) along with neutrophil counts, IL-8/CXCL8 neutralization might exert beneficial effects in pulmonary complications of the disease. This evidence concerns the gene CXCL8 and COVID-19.